These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR. Cancer; 1989 May 01; 63(9):1657-67. PubMed ID: 2467734 [Abstract] [Full Text] [Related]
17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM. J Clin Oncol; 1990 Jan 01; 8(1):39-47. PubMed ID: 2153194 [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T. Jpn J Clin Oncol; 1993 Oct 01; 23(5):291-8. PubMed ID: 7693990 [Abstract] [Full Text] [Related]
19. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E, Mathews RP, Gates J, Levine P, Maiman M, Remy JC. Gynecol Oncol; 1997 May 01; 65(2):348-56. PubMed ID: 9159350 [Abstract] [Full Text] [Related]